Sign in
Taking people in PolandPhase 1

Virus-fighting T-cell therapy for cytomegalovirus infection after stem cell transplant

Tests the safety of virus-specific T cells against resistant cytomegalovirus in adult transplant patients.

Key facts

Who runs it
Wroclaw Medical University
Where
Gdansk, Krakow, Poznan, Warsaw, and Wroclaw, PolandSee the 6 sites
Registry title
A multicenter, open-label, dose-escalation clinical trial to evaluate the safety of viral-specific T-cell (VST) therapy in the treatment of refractory viral infections after allogeneic hematopoietic stem cell transplantation or CAR-T therapy (ALLOVISTA).
Status
Recruiting
Phase
Phase 1
People taking part
18 people, planned
Started
15 Jul 2026
Expected to end
30 Jun 2029
Type of study
Interventional
Record updated
7 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a CMV (cytomegalovirus) infection that does not respond to treatment. Their infection must have come after a stem cell transplant from a donor or after CAR-T therapy.

Age
18 years and older
Sex
All sexes
Disease stage
Viral infection that does not respond to treatment (refractory), after a donor stem cell transplant or CAR-T therapy
Earlier treatment
Must have had a donor (allogeneic) stem cell transplant or CAR-T therapy

Where in Poland

  • Uniwersyteckie Centrum KliniczneGdansk, PolandTaking people
  • Szpital Uniwersytecki w KrakowieKrakow, PolandTaking people
  • Uniwersytecki Szpital Kliniczny w PoznaniuPoznan, PolandTaking people
  • Instytut Hematologii I TransfuzjologiiWarsaw, PolandTaking people
  • Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu MedycznegoWarsaw, PolandTaking people
  • Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we WroclawiuWroclaw, PolandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Virus-fighting T-cell therapy for cytomegalovirus infection after stem cell transplantGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
7 July 2026